Premium
Tumor lysis syndrome following VP‐16‐213 in chronic myeloid leukemia in blast crisis
Author(s) -
Thomas M. Roy,
Robinson W. A.,
Mughal T. I.,
Glode L. Michael
Publication year - 1984
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.2830160211
Subject(s) - tumor lysis syndrome , myeloid leukemia , etoposide , blast crisis , medicine , leukemia , immunology , cytotoxic t cell , chemotherapy , myeloid , cancer research , oncology , biology , biochemistry , in vitro
Several recent reports have emphasized the potentially serious and often fatal acute metabolic complications following cytotoxic chemotherapy in both solid tumors and leukemias. We present here a case of chronic myeloid leukemia in blast crisis who developed an acute tumor lysis syndrome following a single dose of VP‐16‐213 (Etoposide).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom